We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.54B
AUM Growth
+$215M
Cap. Flow
-$203M
Cap. Flow %
-2.69%
Top 10 Hldgs %
62.44%
Holding
434
New
139
Increased
87
Reduced
85
Closed
95

Top Buys

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$118M
2
INCY icon
Incyte
INCY
+$117M
3
GRFS
Grifois
GRFS
+$51.9M
4
HUM icon
Humana
HUM
+$47.4M
5
KO icon
Coca-Cola
KO
+$45.2M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$88.4M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$80.1M
3
FRPT icon
Freshpet
FRPT
+$60.8M
4
AMZN icon
Amazon
AMZN
+$55.1M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$50.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.9%
2 Consumer Staples 5.54%
3 Consumer Discretionary 5.08%
4 Technology 3.55%
5 Communication Services 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SQFTW icon
301
Presidio Property Trust Inc Series A Warrants
SQFTW
$217K
$138K ﹤0.01%
2,000,000
– –
BEATW icon
302
Heartbeam Inc Warrant
BEATW
$41.3K
$125K ﹤0.01%
500,000
– –
GRDX
303
GridAI Technologies Corp
GRDX
$19.2M
$118K ﹤0.01%
+9,000
New +$141K
STAF
304
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
$117K ﹤0.01%
40,200
+15,117
+60% +$50.2K
AMCR icon
305
Amcor
AMCR
$22.1B
$109K ﹤0.01%
+2,294
New +$107K
MOTS
306
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$107K ﹤0.01%
244,000
+125,000
+105% +$99.6K
INM icon
307
InMed Pharmaceuticals
INM
$7.85M
$97.2K ﹤0.01%
13,348
+3,050
+30% +$22.4K
SKYAW
308
SkyAI Inc
SKYAW
$263K
$94.1K ﹤0.01%
1,176,000
– –
TNXP icon
309
Tonix Pharmaceuticals
TNXP
$192M
$91K ﹤0.01%
153
-1,025
-87% -$1.1M
EZRA
310
Reliance Global Group
EZRA
$2.09M
$80.6K ﹤0.01%
349
+117
+50% +$36.3K
MOBBW
311
Mobilicom Ltd Warrants
MOBBW
$2.83B
$79.4K ﹤0.01%
242,100
– –
BBLG
312
Bone Biologics
BBLG
$1.69M
$78.8K ﹤0.01%
+6,167
New +$120K
SCNI
313
Scinai Immunotherapeutics
SCNI
$1.27M
$63.2K ﹤0.01%
12,179
-10,911
-47% -$56.3K
SBEV.WS
314
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$54.2K ﹤0.01%
904,000
– –
DCOY
315
Decoy Therapeutics
DCOY
$2.09M
$44.4K ﹤0.01%
58
-3
-5% -$2.58K
LCFYW icon
316
Locafy Ltd Warrant
LCFYW
$36.2K ﹤0.01%
12,121
-230,304
-95% -$813K
SWAGW icon
317
Stran & Company Warrant
SWAGW
$66.4K
$25.7K ﹤0.01%
545,000
– –
NLSPW
318
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$24.5K ﹤0.01%
500,000
– –
RVSNW icon
319
Rail Vision Ltd Warrant
RVSNW
$725K
$20.4K ﹤0.01%
136,187
-953,313
-88% -$122K
PETVW
320
DELISTED
PetVivo Holdings, Inc. Warrant
PETVW
$20K ﹤0.01%
200,000
– –
HSCSW icon
321
HeartSciences Inc Warrant
HSCSW
$71K
$17.6K ﹤0.01%
352,941
– –
SVREW
322
SaverOne 2014 Ltd Warrant
SVREW
$16.9K ﹤0.01%
242,100
– –
ONFOW icon
323
Onfolio Holdings Warrant
ONFOW
$64.5K
$16.2K ﹤0.01%
400,000
– –
DFSCW
324
DEFSEC Technologies Warrant
DFSCW
$14.4K ﹤0.01%
120,000
– –
NXLIW
325
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$13.6K ﹤0.01%
325,000
– –
11 12
13
14 15

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Armistice Capital held 434 positions worth $7.54B, up 2.9% from $7.33B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital's Q1 2024 filing shows 139 new, 87 increased, 85 reduced and 95 closed positions. Its largest new stake was Cytokinetics: 1,525,688 shares worth $107M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $88.4M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q1 2024 buy was Cytokinetics: 1,525,688 shares worth $107M.
  • Armistice Capital added most to Incyte in Q1 2024, an estimated $117M increase.
  • Armistice Capital's biggest Q1 2024 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $88.4M.
  • Armistice Capital fully exited Jazz Pharmaceuticals in Q1 2024, selling an estimated $80.1M.
  • Armistice Capital's ten largest holdings make up 62% of its $7.54B portfolio in Q1 2024.
  • Armistice Capital opened 139 new positions and closed 95 in Q1 2024.
  • Armistice Capital's portfolio value rose 2.9% quarter-over-quarter to $7.54B.

Based on Armistice Capital's 13F filing for Q1 2024, filed 15 May 2024.